BTIG Maintains Buy on Praxis Precision Medicine, Lowers Price Target to $810
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and lowers the price target from $843 to $810.
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and lowers the price target from $843 to $810.